Add to ORKGAlthough the prophylactic administration of indomethacin in extremely low-birth weight infants reduces the frequency of patent ductus arteriosus and severe intraventricular hemorrhage, it does not appear to provide any long-term benefit in terms of survival without neurosensory and cognitive outcomes. Considering the increased drug-induced reduction in renal, intestinal, and cerebral blood flow, the use of prophylaxis cannot be routinely recommended in preterm neonates. However, a better understanding of the genetic background of each infant may allow for individualized prophylaxis using NSAIDs and metabolomics
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
ImportancePatent ductus arteriosus (PDA) is associated with increased mortality and worsened respira...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
Although the prophylactic administration of indomethacin in extremely low-birth weight infants reduc...
This study was aimed to verify the efficacy and safety of ibuprofen prophylaxis of patent ductus art...
The patent ductus arteriosus contribute to many neonatal morbidities. There are different approaches...
ObjectiveTo determine whether prophylactic indomethacin (PINDO) has more or less morbidity than dela...
neonates. The purpose of this study is to determine the efficacy of prophylactic parenteral acetamin...
Introduction: In the new-born, persistent patent ductus arteriosus is associated with significant mo...
ObjectiveTo determine whether a nonintervention approach for treating hemodynamically significant pa...
A premature infant is at high risk for many complications and multiple morbidities. A patent ductus...
INTRODUCTION: Management of patent ductus arteriosus (PDA) in preterm infants is one of the most con...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
The primary objective of this review is to verify if there are differences in the diagnostic and the...
_Background:_ Much controversy exists about the optimal management of a patent ductus arteriosus (PD...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
ImportancePatent ductus arteriosus (PDA) is associated with increased mortality and worsened respira...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
Although the prophylactic administration of indomethacin in extremely low-birth weight infants reduc...
This study was aimed to verify the efficacy and safety of ibuprofen prophylaxis of patent ductus art...
The patent ductus arteriosus contribute to many neonatal morbidities. There are different approaches...
ObjectiveTo determine whether prophylactic indomethacin (PINDO) has more or less morbidity than dela...
neonates. The purpose of this study is to determine the efficacy of prophylactic parenteral acetamin...
Introduction: In the new-born, persistent patent ductus arteriosus is associated with significant mo...
ObjectiveTo determine whether a nonintervention approach for treating hemodynamically significant pa...
A premature infant is at high risk for many complications and multiple morbidities. A patent ductus...
INTRODUCTION: Management of patent ductus arteriosus (PDA) in preterm infants is one of the most con...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
The primary objective of this review is to verify if there are differences in the diagnostic and the...
_Background:_ Much controversy exists about the optimal management of a patent ductus arteriosus (PD...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...
ImportancePatent ductus arteriosus (PDA) is associated with increased mortality and worsened respira...
Background: Much controversy exists about the optimal management of a patent ductus arteriosus (FDA)...